Digging Into Office of Prescription Drug Promotion Violation Letters
Executive Summary
Risk-related violations were the most popular and Tuesday and Thursday were the days letters were most often issued in 2011. FDA also continued its trend of issuing more letters directing violators to only stop using the questionable promotion, rather than also requiring new truthful ads be disseminated.